nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—Mitomycin—stomach cancer	0.239	0.411	CbGbCtD
Sitagliptin—CYP2C8—Fluorouracil—stomach cancer	0.087	0.149	CbGbCtD
Sitagliptin—ABCB1—Irinotecan—stomach cancer	0.0613	0.105	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—stomach cancer	0.0449	0.0772	CbGbCtD
Sitagliptin—CYP3A4—Irinotecan—stomach cancer	0.0367	0.0631	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—stomach cancer	0.0335	0.0576	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—stomach cancer	0.0325	0.0558	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—stomach cancer	0.0269	0.0463	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—stomach cancer	0.0201	0.0345	CbGbCtD
Sitagliptin—DPP4—blood vessel—stomach cancer	0.00826	0.147	CbGeAlD
Sitagliptin—DPP4—hematopoietic system—stomach cancer	0.0044	0.0781	CbGeAlD
Sitagliptin—DPP4—epithelium—stomach cancer	0.00402	0.0714	CbGeAlD
Sitagliptin—DPP4—smooth muscle tissue—stomach cancer	0.00388	0.0688	CbGeAlD
Sitagliptin—DPP4—pancreas—stomach cancer	0.00358	0.0636	CbGeAlD
Sitagliptin—DPP4—lymphoid tissue—stomach cancer	0.0031	0.055	CbGeAlD
Sitagliptin—DPP4—digestive system—stomach cancer	0.00306	0.0543	CbGeAlD
Sitagliptin—DPP4—bone marrow—stomach cancer	0.00282	0.05	CbGeAlD
Sitagliptin—DPP4—endocrine gland—stomach cancer	0.00253	0.0449	CbGeAlD
Sitagliptin—DPP4—liver—stomach cancer	0.00228	0.0404	CbGeAlD
Sitagliptin—CYP2C8—hematopoietic system—stomach cancer	0.00212	0.0376	CbGeAlD
Sitagliptin—ABCB1—blood vessel—stomach cancer	0.00191	0.0338	CbGeAlD
Sitagliptin—DPP4—lymph node—stomach cancer	0.00175	0.031	CbGeAlD
Sitagliptin—CYP3A4—hematopoietic system—stomach cancer	0.00143	0.0255	CbGeAlD
Sitagliptin—CYP2C8—endocrine gland—stomach cancer	0.00122	0.0216	CbGeAlD
Sitagliptin—CYP2C8—liver—stomach cancer	0.0011	0.0195	CbGeAlD
Sitagliptin—ABCB1—hematopoietic system—stomach cancer	0.00102	0.018	CbGeAlD
Sitagliptin—CYP3A4—digestive system—stomach cancer	0.000998	0.0177	CbGeAlD
Sitagliptin—ABCB1—epithelium—stomach cancer	0.000928	0.0165	CbGeAlD
Sitagliptin—ABCB1—pancreas—stomach cancer	0.000827	0.0147	CbGeAlD
Sitagliptin—CYP3A4—endocrine gland—stomach cancer	0.000825	0.0146	CbGeAlD
Sitagliptin—CYP3A4—liver—stomach cancer	0.000743	0.0132	CbGeAlD
Sitagliptin—ABCB1—lymphoid tissue—stomach cancer	0.000715	0.0127	CbGeAlD
Sitagliptin—ABCB1—digestive system—stomach cancer	0.000706	0.0125	CbGeAlD
Sitagliptin—ABCB1—bone marrow—stomach cancer	0.000651	0.0116	CbGeAlD
Sitagliptin—ABCB1—endocrine gland—stomach cancer	0.000584	0.0104	CbGeAlD
Sitagliptin—ABCB1—liver—stomach cancer	0.000526	0.00933	CbGeAlD
Sitagliptin—ABCB1—lymph node—stomach cancer	0.000403	0.00716	CbGeAlD
Sitagliptin—Neuropathy peripheral—Epirubicin—stomach cancer	0.000394	0.00134	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000394	0.00134	CcSEcCtD
Sitagliptin—Cough—Capecitabine—stomach cancer	0.000394	0.00134	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—stomach cancer	0.000391	0.00133	CcSEcCtD
Sitagliptin—Hypertension—Capecitabine—stomach cancer	0.00039	0.00132	CcSEcCtD
Sitagliptin—Hypersensitivity—Fluorouracil—stomach cancer	0.000388	0.00132	CcSEcCtD
Sitagliptin—Dry mouth—Docetaxel—stomach cancer	0.000388	0.00132	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000388	0.00132	CcSEcCtD
Sitagliptin—Arthralgia—Capecitabine—stomach cancer	0.000384	0.00131	CcSEcCtD
Sitagliptin—Myalgia—Capecitabine—stomach cancer	0.000384	0.00131	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—stomach cancer	0.000383	0.0013	CcSEcCtD
Sitagliptin—Anxiety—Capecitabine—stomach cancer	0.000383	0.0013	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000381	0.0013	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—stomach cancer	0.000381	0.0013	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—stomach cancer	0.00038	0.00129	CcSEcCtD
Sitagliptin—Anaphylactic shock—Docetaxel—stomach cancer	0.00038	0.00129	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—stomach cancer	0.00038	0.00129	CcSEcCtD
Sitagliptin—Discomfort—Capecitabine—stomach cancer	0.00038	0.00129	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—stomach cancer	0.000378	0.00129	CcSEcCtD
Sitagliptin—Infection—Docetaxel—stomach cancer	0.000378	0.00129	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—stomach cancer	0.000377	0.00128	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—stomach cancer	0.000377	0.00128	CcSEcCtD
Sitagliptin—Diarrhoea—Irinotecan—stomach cancer	0.000376	0.00128	CcSEcCtD
Sitagliptin—Dry mouth—Capecitabine—stomach cancer	0.000376	0.00128	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—stomach cancer	0.000374	0.00127	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—stomach cancer	0.000373	0.00127	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—stomach cancer	0.000372	0.00127	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—stomach cancer	0.000372	0.00127	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—stomach cancer	0.000369	0.00126	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000369	0.00125	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—stomach cancer	0.000366	0.00124	CcSEcCtD
Sitagliptin—Infection—Capecitabine—stomach cancer	0.000366	0.00124	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—stomach cancer	0.000365	0.00124	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000365	0.00124	CcSEcCtD
Sitagliptin—Dizziness—Irinotecan—stomach cancer	0.000364	0.00124	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—stomach cancer	0.000362	0.00123	CcSEcCtD
Sitagliptin—Nervous system disorder—Capecitabine—stomach cancer	0.000361	0.00123	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—stomach cancer	0.000361	0.00123	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—stomach cancer	0.000361	0.00123	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—stomach cancer	0.000359	0.00122	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—stomach cancer	0.000358	0.00122	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—stomach cancer	0.000358	0.00122	CcSEcCtD
Sitagliptin—Skin disorder—Capecitabine—stomach cancer	0.000358	0.00122	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—stomach cancer	0.000357	0.00121	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—stomach cancer	0.000356	0.00121	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—stomach cancer	0.000355	0.00121	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—stomach cancer	0.000354	0.0012	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000352	0.0012	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—stomach cancer	0.00035	0.00119	CcSEcCtD
Sitagliptin—Vomiting—Irinotecan—stomach cancer	0.00035	0.00119	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—stomach cancer	0.000349	0.00119	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—stomach cancer	0.000349	0.00119	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—stomach cancer	0.000348	0.00119	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—stomach cancer	0.000348	0.00118	CcSEcCtD
Sitagliptin—Rash—Irinotecan—stomach cancer	0.000347	0.00118	CcSEcCtD
Sitagliptin—Dermatitis—Irinotecan—stomach cancer	0.000347	0.00118	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000347	0.00118	CcSEcCtD
Sitagliptin—Headache—Irinotecan—stomach cancer	0.000345	0.00117	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—stomach cancer	0.000344	0.00117	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—stomach cancer	0.000341	0.00116	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—stomach cancer	0.000338	0.00115	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—stomach cancer	0.000338	0.00115	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—stomach cancer	0.000337	0.00115	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—stomach cancer	0.000336	0.00114	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000336	0.00114	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—stomach cancer	0.000335	0.00114	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—stomach cancer	0.000335	0.00114	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—stomach cancer	0.000335	0.00114	CcSEcCtD
Sitagliptin—Insomnia—Capecitabine—stomach cancer	0.000333	0.00113	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—stomach cancer	0.000332	0.00113	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—stomach cancer	0.000332	0.00113	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—stomach cancer	0.000332	0.00113	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—stomach cancer	0.000332	0.00113	CcSEcCtD
Sitagliptin—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000331	0.0049	CbGpPWpGaD
Sitagliptin—Decreased appetite—Docetaxel—stomach cancer	0.000331	0.00112	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—stomach cancer	0.00033	0.00112	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—stomach cancer	0.00033	0.00112	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—stomach cancer	0.000329	0.00112	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000328	0.00112	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000328	0.00112	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—stomach cancer	0.000328	0.00112	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000328	0.00486	CbGpPWpGaD
Sitagliptin—Angiopathy—Epirubicin—stomach cancer	0.000328	0.00111	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—stomach cancer	0.000328	0.00111	CcSEcCtD
Sitagliptin—Nausea—Irinotecan—stomach cancer	0.000327	0.00111	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—stomach cancer	0.000326	0.00111	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—stomach cancer	0.000325	0.00111	CcSEcCtD
Sitagliptin—Pain—Docetaxel—stomach cancer	0.000325	0.00111	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—stomach cancer	0.000325	0.00111	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000325	0.00481	CbGpPWpGaD
Sitagliptin—Back pain—Methotrexate—stomach cancer	0.000325	0.00111	CcSEcCtD
Sitagliptin—Dyspepsia—Capecitabine—stomach cancer	0.000324	0.0011	CcSEcCtD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000321	0.00475	CbGpPWpGaD
Sitagliptin—Decreased appetite—Capecitabine—stomach cancer	0.00032	0.00109	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000318	0.00108	CcSEcCtD
Sitagliptin—Fatigue—Capecitabine—stomach cancer	0.000317	0.00108	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—stomach cancer	0.000317	0.00108	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—stomach cancer	0.000316	0.00108	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—stomach cancer	0.000316	0.00107	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NPM1—stomach cancer	0.000316	0.00468	CbGpPWpGaD
Sitagliptin—Pain—Capecitabine—stomach cancer	0.000315	0.00107	CcSEcCtD
Sitagliptin—Constipation—Capecitabine—stomach cancer	0.000315	0.00107	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—stomach cancer	0.000314	0.00107	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—stomach cancer	0.000313	0.00107	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—stomach cancer	0.000313	0.00106	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—stomach cancer	0.000312	0.00106	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—stomach cancer	0.000312	0.00106	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000311	0.00106	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—stomach cancer	0.00031	0.00105	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—stomach cancer	0.00031	0.00105	CcSEcCtD
Sitagliptin—Tension—Epirubicin—stomach cancer	0.000308	0.00105	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—stomach cancer	0.000305	0.00104	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—stomach cancer	0.000304	0.00103	CcSEcCtD
Sitagliptin—Feeling abnormal—Capecitabine—stomach cancer	0.000303	0.00103	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—stomach cancer	0.000303	0.00103	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—stomach cancer	0.000303	0.00103	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—stomach cancer	0.000302	0.00103	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—stomach cancer	0.000302	0.00103	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—stomach cancer	0.000302	0.00103	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000301	0.00102	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000301	0.00102	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—stomach cancer	0.000301	0.00102	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—RPL15—stomach cancer	0.000298	0.00441	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—HSPD1—stomach cancer	0.000298	0.00441	CbGpPWpGaD
Sitagliptin—Vision blurred—Epirubicin—stomach cancer	0.000296	0.00101	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—stomach cancer	0.000295	0.00436	CbGpPWpGaD
Sitagliptin—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000294	0.00436	CbGpPWpGaD
Sitagliptin—Cough—Methotrexate—stomach cancer	0.000293	0.000997	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—stomach cancer	0.000293	0.000996	CcSEcCtD
Sitagliptin—Urticaria—Capecitabine—stomach cancer	0.000293	0.000995	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—stomach cancer	0.000292	0.000992	CcSEcCtD
Sitagliptin—Abdominal pain—Capecitabine—stomach cancer	0.000291	0.00099	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—stomach cancer	0.000291	0.000989	CcSEcCtD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000288	0.00427	CbGpPWpGaD
Sitagliptin—Flatulence—Doxorubicin—stomach cancer	0.000287	0.000975	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—stomach cancer	0.000286	0.000973	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—stomach cancer	0.000286	0.000973	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—stomach cancer	0.000285	0.000971	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000284	0.000966	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—stomach cancer	0.000283	0.000964	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—stomach cancer	0.000283	0.000961	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—stomach cancer	0.000282	0.000961	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—stomach cancer	0.000282	0.00096	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—stomach cancer	0.000281	0.000957	CcSEcCtD
Sitagliptin—Hypersensitivity—Docetaxel—stomach cancer	0.00028	0.000953	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—stomach cancer	0.00028	0.000951	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—RPS26—stomach cancer	0.000278	0.00412	CbGpPWpGaD
Sitagliptin—Cough—Epirubicin—stomach cancer	0.000274	0.000933	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—stomach cancer	0.000274	0.000932	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—stomach cancer	0.000274	0.000932	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—stomach cancer	0.000273	0.000928	CcSEcCtD
Sitagliptin—Infection—Methotrexate—stomach cancer	0.000272	0.000926	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—stomach cancer	0.000271	0.000923	CcSEcCtD
Sitagliptin—Hypersensitivity—Capecitabine—stomach cancer	0.000271	0.000923	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—stomach cancer	0.00027	0.000918	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—stomach cancer	0.000269	0.000914	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—stomach cancer	0.000268	0.00091	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—stomach cancer	0.000268	0.00091	CcSEcCtD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000267	0.00396	CbGpPWpGaD
Sitagliptin—Anxiety—Epirubicin—stomach cancer	0.000267	0.000907	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—stomach cancer	0.000266	0.000906	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000266	0.000904	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—stomach cancer	0.000264	0.000899	CcSEcCtD
Sitagliptin—Asthenia—Capecitabine—stomach cancer	0.000264	0.000899	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000263	0.0039	CbGpPWpGaD
Sitagliptin—Malaise—Doxorubicin—stomach cancer	0.000262	0.000892	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—stomach cancer	0.000262	0.00089	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—stomach cancer	0.000261	0.000889	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—stomach cancer	0.00026	0.000885	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—stomach cancer	0.000257	0.000873	CcSEcCtD
Sitagliptin—Infection—Epirubicin—stomach cancer	0.000255	0.000867	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000255	0.00377	CbGpPWpGaD
Sitagliptin—Cough—Doxorubicin—stomach cancer	0.000254	0.000863	CcSEcCtD
Sitagliptin—Diarrhoea—Capecitabine—stomach cancer	0.000252	0.000857	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—IGFBP3—stomach cancer	0.000252	0.00373	CbGpPWpGaD
Sitagliptin—Nervous system disorder—Epirubicin—stomach cancer	0.000252	0.000856	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—stomach cancer	0.000252	0.000855	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—stomach cancer	0.000251	0.000854	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00025	0.000849	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—stomach cancer	0.000249	0.000847	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.000249	0.00368	CbGpPWpGaD
Sitagliptin—Insomnia—Methotrexate—stomach cancer	0.000248	0.000843	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—stomach cancer	0.000248	0.000842	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—stomach cancer	0.000248	0.000842	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—stomach cancer	0.000247	0.000839	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000246	0.000836	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—stomach cancer	0.000245	0.000832	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—stomach cancer	0.000244	0.000829	CcSEcCtD
Sitagliptin—Dizziness—Capecitabine—stomach cancer	0.000244	0.000828	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—stomach cancer	0.000242	0.000824	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—stomach cancer	0.000242	0.000822	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—stomach cancer	0.000241	0.000821	CcSEcCtD
Sitagliptin—Rash—Docetaxel—stomach cancer	0.00024	0.000816	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—stomach cancer	0.00024	0.000815	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—stomach cancer	0.000238	0.00081	CcSEcCtD
Sitagliptin—Headache—Docetaxel—stomach cancer	0.000238	0.00081	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000237	0.000807	CcSEcCtD
Sitagliptin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000237	0.00351	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000237	0.000805	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—stomach cancer	0.000236	0.000804	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—RPS19—stomach cancer	0.000236	0.0035	CbGpPWpGaD
Sitagliptin—Infection—Doxorubicin—stomach cancer	0.000236	0.000802	CcSEcCtD
Sitagliptin—Pain—Methotrexate—stomach cancer	0.000234	0.000797	CcSEcCtD
Sitagliptin—Vomiting—Capecitabine—stomach cancer	0.000234	0.000796	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—PAX6—stomach cancer	0.000234	0.00346	CbGpPWpGaD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000234	0.000795	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—stomach cancer	0.000233	0.000792	CcSEcCtD
Sitagliptin—Rash—Capecitabine—stomach cancer	0.000232	0.00079	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—stomach cancer	0.000232	0.000789	CcSEcCtD
Sitagliptin—Dermatitis—Capecitabine—stomach cancer	0.000232	0.000789	CcSEcCtD
Sitagliptin—Headache—Capecitabine—stomach cancer	0.000231	0.000785	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—stomach cancer	0.000231	0.000784	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—stomach cancer	0.000228	0.000776	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—stomach cancer	0.000226	0.000768	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—stomach cancer	0.000226	0.000768	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—stomach cancer	0.000226	0.000768	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000224	0.000762	CcSEcCtD
Sitagliptin—ABCB1—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000223	0.00331	CbGpPWpGaD
Sitagliptin—Decreased appetite—Epirubicin—stomach cancer	0.000223	0.000758	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000221	0.000753	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—stomach cancer	0.000221	0.000752	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—stomach cancer	0.000219	0.000746	CcSEcCtD
Sitagliptin—Pain—Epirubicin—stomach cancer	0.000219	0.000746	CcSEcCtD
Sitagliptin—Nausea—Capecitabine—stomach cancer	0.000219	0.000744	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—stomach cancer	0.000218	0.000741	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—stomach cancer	0.000217	0.000737	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000216	0.000736	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—stomach cancer	0.000215	0.00073	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—stomach cancer	0.000211	0.000719	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—stomach cancer	0.000211	0.000718	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—stomach cancer	0.00021	0.000713	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—RPS6—stomach cancer	0.000209	0.0031	CbGpPWpGaD
Sitagliptin—Dyspepsia—Doxorubicin—stomach cancer	0.000209	0.000711	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ACE—stomach cancer	0.000207	0.00307	CbGpPWpGaD
Sitagliptin—Decreased appetite—Doxorubicin—stomach cancer	0.000206	0.000702	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000206	0.00305	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000205	0.000697	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—stomach cancer	0.000205	0.000696	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—stomach cancer	0.000204	0.000693	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—stomach cancer	0.000203	0.00069	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—stomach cancer	0.000203	0.00069	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—stomach cancer	0.000203	0.00069	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—stomach cancer	0.000202	0.000687	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—stomach cancer	0.000197	0.000669	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—stomach cancer	0.000196	0.000665	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000194	0.00066	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—stomach cancer	0.000189	0.000643	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—stomach cancer	0.000189	0.000641	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—stomach cancer	0.000188	0.000638	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—stomach cancer	0.000188	0.000638	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—stomach cancer	0.000184	0.000626	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	0.000181	0.00269	CbGpPWpGaD
Sitagliptin—Dizziness—Methotrexate—stomach cancer	0.000181	0.000617	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—stomach cancer	0.000176	0.000597	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—stomach cancer	0.000175	0.000595	CcSEcCtD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000174	0.00258	CbGpPWpGaD
Sitagliptin—Vomiting—Methotrexate—stomach cancer	0.000174	0.000593	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	0.000174	0.00258	CbGpPWpGaD
Sitagliptin—Rash—Methotrexate—stomach cancer	0.000173	0.000588	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—stomach cancer	0.000173	0.000587	CcSEcCtD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000172	0.00255	CbGpPWpGaD
Sitagliptin—Headache—Methotrexate—stomach cancer	0.000172	0.000584	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—stomach cancer	0.00017	0.000579	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—stomach cancer	0.00017	0.000577	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000167	0.00247	CbGpPWpGaD
Sitagliptin—Vomiting—Epirubicin—stomach cancer	0.000163	0.000555	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—stomach cancer	0.000163	0.000554	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—stomach cancer	0.000162	0.000552	CcSEcCtD
Sitagliptin—Rash—Epirubicin—stomach cancer	0.000162	0.00055	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—stomach cancer	0.000162	0.00055	CcSEcCtD
Sitagliptin—Headache—Epirubicin—stomach cancer	0.000161	0.000547	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—stomach cancer	0.000157	0.000534	CcSEcCtD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000157	0.00232	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000153	0.00227	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000153	0.00227	CbGpPWpGaD
Sitagliptin—Nausea—Epirubicin—stomach cancer	0.000152	0.000518	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—stomach cancer	0.000151	0.000513	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—stomach cancer	0.00015	0.000509	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—stomach cancer	0.00015	0.000509	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—stomach cancer	0.000149	0.000506	CcSEcCtD
Sitagliptin—ABCB1—Allograft Rejection—IL10—stomach cancer	0.000146	0.00217	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTT1—stomach cancer	0.000142	0.0021	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000141	0.00209	CbGpPWpGaD
Sitagliptin—Nausea—Doxorubicin—stomach cancer	0.000141	0.00048	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—CYP2A6—stomach cancer	0.00014	0.00207	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000137	0.00202	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—AKR1C3—stomach cancer	0.000134	0.00199	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000134	0.00198	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000127	0.00188	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000122	0.00181	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000116	0.00172	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	0.000115	0.0017	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.000109	0.00162	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000104	0.00154	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP2—stomach cancer	0.000103	0.00153	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000102	0.00151	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP8—stomach cancer	0.000101	0.0015	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	9.92e-05	0.00147	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTP1—stomach cancer	9.81e-05	0.00145	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTP1—stomach cancer	9.68e-05	0.00143	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	9.07e-05	0.00134	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTM1—stomach cancer	9.02e-05	0.00134	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTM1—stomach cancer	8.89e-05	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	8.76e-05	0.0013	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	8.59e-05	0.00127	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CXCL8—stomach cancer	8.56e-05	0.00127	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACAD8—stomach cancer	8.44e-05	0.00125	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	8.25e-05	0.00122	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CXCL8—stomach cancer	8e-05	0.00119	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	7.75e-05	0.00115	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL1B—stomach cancer	7.68e-05	0.00114	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTT1—stomach cancer	7.6e-05	0.00113	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	7.57e-05	0.00112	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GMPR2—stomach cancer	7.52e-05	0.00111	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	7.51e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	7.51e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	7.44e-05	0.0011	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACAD8—stomach cancer	7.35e-05	0.00109	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	7.31e-05	0.00108	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	7.26e-05	0.00108	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	7.21e-05	0.00107	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—RORA—stomach cancer	7.17e-05	0.00106	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH3B—stomach cancer	6.88e-05	0.00102	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SUCLG1—stomach cancer	6.88e-05	0.00102	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.83e-05	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GMPR2—stomach cancer	6.55e-05	0.00097	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—stomach cancer	6.5e-05	0.000963	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NDUFS1—stomach cancer	6.39e-05	0.000947	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NDUFV1—stomach cancer	6.39e-05	0.000947	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.25e-05	0.000925	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SUCLG1—stomach cancer	5.99e-05	0.000887	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH3B—stomach cancer	5.99e-05	0.000887	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	5.7e-05	0.000844	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PGLS—stomach cancer	5.7e-05	0.000844	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BLVRB—stomach cancer	5.7e-05	0.000844	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—stomach cancer	5.57e-05	0.000825	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NDUFV1—stomach cancer	5.57e-05	0.000825	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NDUFS1—stomach cancer	5.57e-05	0.000825	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPAP2A—stomach cancer	5.44e-05	0.000805	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	5.36e-05	0.000794	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—stomach cancer	5.27e-05	0.00078	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.23e-05	0.000774	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	5.19e-05	0.000769	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	5e-05	0.00074	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PGLS—stomach cancer	4.96e-05	0.000735	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BLVRB—stomach cancer	4.96e-05	0.000735	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FBP1—stomach cancer	4.85e-05	0.000718	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NDUFA2—stomach cancer	4.85e-05	0.000718	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CKB—stomach cancer	4.85e-05	0.000718	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA1—stomach cancer	4.85e-05	0.000718	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.84e-05	0.000717	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.77e-05	0.000707	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPAP2A—stomach cancer	4.74e-05	0.000701	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLIN2—stomach cancer	4.56e-05	0.000675	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACAD8—stomach cancer	4.53e-05	0.000671	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA2—stomach cancer	4.43e-05	0.000656	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NT5E—stomach cancer	4.32e-05	0.00064	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PGAM1—stomach cancer	4.32e-05	0.00064	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CKB—stomach cancer	4.22e-05	0.000625	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA1—stomach cancer	4.22e-05	0.000625	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NDUFA2—stomach cancer	4.22e-05	0.000625	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FBP1—stomach cancer	4.22e-05	0.000625	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.17e-05	0.000617	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDH7A1—stomach cancer	4.12e-05	0.00061	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLCE1—stomach cancer	4.12e-05	0.00061	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	4.07e-05	0.000603	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GMPR2—stomach cancer	4.04e-05	0.000598	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLIN2—stomach cancer	3.97e-05	0.000588	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—UMPS—stomach cancer	3.95e-05	0.000585	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA2—stomach cancer	3.86e-05	0.000572	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.86e-05	0.000571	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PGAM1—stomach cancer	3.76e-05	0.000557	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NT5E—stomach cancer	3.76e-05	0.000557	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.69e-05	0.000547	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH3B—stomach cancer	3.69e-05	0.000547	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.68e-05	0.000545	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.67e-05	0.000544	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PDHA1—stomach cancer	3.67e-05	0.000544	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ECHS1—stomach cancer	3.67e-05	0.000544	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLCE1—stomach cancer	3.59e-05	0.000532	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.59e-05	0.000532	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.56e-05	0.000527	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.47e-05	0.000515	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMP—stomach cancer	3.45e-05	0.000511	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FADS1—stomach cancer	3.45e-05	0.000511	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UMPS—stomach cancer	3.44e-05	0.00051	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.43e-05	0.000508	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.43e-05	0.000508	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SREBF2—stomach cancer	3.23e-05	0.000479	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.21e-05	0.000475	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PDHA1—stomach cancer	3.2e-05	0.000474	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ECHS1—stomach cancer	3.2e-05	0.000474	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—RORA—stomach cancer	3.19e-05	0.000473	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.08e-05	0.000456	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PGLS—stomach cancer	3.06e-05	0.000453	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BLVRB—stomach cancer	3.06e-05	0.000453	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.03e-05	0.000449	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FADS1—stomach cancer	3.01e-05	0.000445	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMP—stomach cancer	3.01e-05	0.000445	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDOB—stomach cancer	2.99e-05	0.000443	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.95e-05	0.000437	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.92e-05	0.000432	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.89e-05	0.000428	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.89e-05	0.000428	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.82e-05	0.000418	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SREBF2—stomach cancer	2.82e-05	0.000417	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.82e-05	0.000417	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—RORA—stomach cancer	2.78e-05	0.000412	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALOX5—stomach cancer	2.78e-05	0.000412	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.75e-05	0.000407	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—DPYD—stomach cancer	2.74e-05	0.000405	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.73e-05	0.000404	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDOB—stomach cancer	2.61e-05	0.000386	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.6e-05	0.000385	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CKB—stomach cancer	2.6e-05	0.000385	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA1—stomach cancer	2.6e-05	0.000385	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FBP1—stomach cancer	2.6e-05	0.000385	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.51e-05	0.000371	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.48e-05	0.000368	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLIN2—stomach cancer	2.45e-05	0.000362	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALOX5—stomach cancer	2.42e-05	0.000359	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.42e-05	0.000359	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—stomach cancer	2.42e-05	0.000359	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2A6—stomach cancer	2.39e-05	0.000354	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—DPYD—stomach cancer	2.39e-05	0.000353	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA2—stomach cancer	2.38e-05	0.000352	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.33e-05	0.000346	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKR1C3—stomach cancer	2.33e-05	0.000345	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PGAM1—stomach cancer	2.32e-05	0.000343	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NT5E—stomach cancer	2.32e-05	0.000343	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO1—stomach cancer	2.27e-05	0.000336	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.23e-05	0.00033	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLCE1—stomach cancer	2.21e-05	0.000328	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.21e-05	0.000328	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UMPS—stomach cancer	2.12e-05	0.000314	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—stomach cancer	2.11e-05	0.000312	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2A6—stomach cancer	2.08e-05	0.000309	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKR1C3—stomach cancer	2.03e-05	0.0003	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CD44—stomach cancer	2.01e-05	0.000298	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO1—stomach cancer	1.98e-05	0.000293	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PDHA1—stomach cancer	1.97e-05	0.000292	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ECHS1—stomach cancer	1.97e-05	0.000292	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.95e-05	0.000289	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FADS1—stomach cancer	1.85e-05	0.000274	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMP—stomach cancer	1.85e-05	0.000274	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.85e-05	0.000274	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CD44—stomach cancer	1.75e-05	0.00026	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SREBF2—stomach cancer	1.74e-05	0.000257	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—RORA—stomach cancer	1.71e-05	0.000254	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.71e-05	0.000253	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—stomach cancer	1.68e-05	0.000249	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMOX1—stomach cancer	1.65e-05	0.000245	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDOB—stomach cancer	1.61e-05	0.000238	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMS—stomach cancer	1.56e-05	0.000231	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—stomach cancer	1.54e-05	0.000228	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALOX5—stomach cancer	1.49e-05	0.000221	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.49e-05	0.000221	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—DPYD—stomach cancer	1.47e-05	0.000218	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—stomach cancer	1.46e-05	0.000217	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ERCC2—stomach cancer	1.45e-05	0.000215	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMOX1—stomach cancer	1.44e-05	0.000214	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—stomach cancer	1.36e-05	0.000202	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMS—stomach cancer	1.36e-05	0.000201	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—stomach cancer	1.34e-05	0.000199	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—stomach cancer	1.3e-05	0.000192	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.28e-05	0.00019	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ERCC2—stomach cancer	1.26e-05	0.000187	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CAV1—stomach cancer	1.26e-05	0.000186	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—APOA1—stomach cancer	1.25e-05	0.000186	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.25e-05	0.000185	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO1—stomach cancer	1.22e-05	0.00018	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.2e-05	0.000178	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—stomach cancer	1.19e-05	0.000176	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—stomach cancer	1.11e-05	0.000164	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CAV1—stomach cancer	1.1e-05	0.000162	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—APOA1—stomach cancer	1.09e-05	0.000162	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CD44—stomach cancer	1.08e-05	0.00016	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—stomach cancer	9.94e-06	0.000147	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—stomach cancer	9.63e-06	0.000143	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NOS3—stomach cancer	9.51e-06	0.000141	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	9.18e-06	0.000136	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—stomach cancer	9.01e-06	0.000133	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMOX1—stomach cancer	8.88e-06	0.000132	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—stomach cancer	8.69e-06	0.000129	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—stomach cancer	8.66e-06	0.000128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMS—stomach cancer	8.37e-06	0.000124	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NOS3—stomach cancer	8.28e-06	0.000123	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—stomach cancer	8.28e-06	0.000123	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ERCC2—stomach cancer	7.78e-06	0.000115	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—stomach cancer	7.57e-06	0.000112	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—stomach cancer	7.32e-06	0.000108	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CAV1—stomach cancer	6.75e-06	9.99e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—APOA1—stomach cancer	6.73e-06	9.97e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—stomach cancer	5.93e-06	8.79e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—stomach cancer	5.35e-06	7.92e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—stomach cancer	5.33e-06	7.9e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NOS3—stomach cancer	5.1e-06	7.56e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—stomach cancer	4.67e-06	6.91e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—stomach cancer	4.66e-06	6.9e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.87e-06	4.25e-05	CbGpPWpGaD
